Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Zeenat Qureshi Stroke Institute (ZQSI) is a prominent non-profit research organization dedicated to advancing the science of stroke treatment and cardiovascular health. Headquartered in Minnesota, the institute specializes in designing and conducting large-scale, multi-center clinical trials that evaluate novel pharmacological and interventional strategies. ZQSI is widely recognized for its leadership in the ATACH (Antihypertensive Treatment of Acute Cerebral Hemorrhage) trials, which have significantly influenced clinical guidelines for blood pressure management in stroke patients. In addition to clinical research, the institute provides comprehensive educational resources, including fellowships and certification programs for medical professionals. By fostering global collaborations, ZQSI aims to improve patient outcomes through evidence-based medicine and innovative healthcare delivery models.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zeenat Qureshi Stroke Institute.